Meeting
2013 Genitourinary Cancers Symposium
Assocation of Gleason 9-10 prostate cancer with worse outcomes compared to Gleason 8 disease.
Authors
Che-Kai Tsao
Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY
Che-Kai Tsao , Kathryn P. Gray , Mari Nakabayashi , Caroline Evan , Matt D. Galsky , Philip W. Kantoff , William K. Oh , Mark Pomerantz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 31, 2013 (suppl 6; abstr 157)
DOI
10.1200/jco.2013.31.6_suppl.157
Abstract #
157
Poster Bd #
K6
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Outcomes of men with ductal prostate cancer undergoing definitive therapy for localized disease.
First Author: Weranja Kalana Bodhisiri Ranasinghe
Poster
2024 ASCO Annual Meeting
Clinical characteristics and treatment patterns of patients with high-risk localized prostate cancer (HR LPC) treated with radical prostatectomy (RP) and perioperative hormonal therapy (HT) in Japan, South Korea, and Taiwan.
First Author: Shingo Hatakeyama
Poster
2023 ASCO Annual Meeting
Post radical prostatectomy (RP) PSA outcomes following 6 vs 18 months of perioperative androgen deprivation therapy (ADT) in men with localized high risk prostate cancer (LHRPC): Results of Part 2 of a randomized phase 2 trial.
First Author: Rana R. McKay
Poster
2023 ASCO Genitourinary Cancers Symposium
Pelvic clinical node-positive prostate cancer: Impact of radiotherapy and nodal disease burden.
First Author: Tony Felefly